Through a combination of UFLC-TOF-MS, network pharmacology, and experimental validation, we found that FDT attenuated atherosclerosis and exerted anti-inflammatory effects by suppressing SELP and CCL2 gene expression, contributing to monocyte adhesion and migration. This evidence concerns the gene CCL2 and atherosclerosis.